These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 37515246)

  • 1. Evaluation of humoral immune response in relation to COVID-19 severity over 1 year post-infection: critical cases higher humoral immune response than mild cases.
    Bang MS; Kim CM; Cho NH; Seo JW; Kim DY; Yun NR; Kim DM
    Front Immunol; 2023; 14():1203803. PubMed ID: 37545518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term risk of death and readmission after hospital admission with covid-19 among older adults: retrospective cohort study.
    Oseran AS; Song Y; Xu J; Dahabreh IJ; Wadhera RK; de Lemos JA; Das SR; Sun T; Yeh RW; Kazi DS
    BMJ; 2023 Aug; 382():e076222. PubMed ID: 37558240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severity of SARS-CoV-2 Omicron XBB subvariants in Singapore.
    Pung R; Kong XP; Cui L; Chae SR; Chen MI; Lee VJ; Ho ZJM
    Lancet Reg Health West Pac; 2023 Aug; 37():100849. PubMed ID: 37554470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with antibody titer levels among an occupational cohort of fully vaccinated individuals and subsequent risk of COVID-19 infection: A cohort study.
    Wasserman EB; Sills AK; Martins D; Casolaro A; Walton P; Anderson D; Pasha S; O'Neal C; Eichner D; Osterholm M; Mancell J; Mack CD
    J Med Virol; 2023 Aug; 95(8):e28999. PubMed ID: 37554019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does monoclonal antibody treatment for COVID-19 impact short and long-term outcomes in a large generalisable population? A retrospective cohort study in the USA.
    Griffin D; McNeil C; Okusa J; Berrent D; Guo Y; Daugherty SE
    BMJ Open; 2023 Aug; 13(8):e069247. PubMed ID: 37553188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors.
    Saigal A; Nagoda Niklewicz C; Naidu SB; Bintalib HM; Shah AJ; Seligmann G; Hunter AS; Wey E; Abubakar I; Mahungu T; Miller D; Barnett J; Jain NG; Brill S; Goldring J; Jarvis H; Smith C; Ogbonnaya C; Hurst JR; Lipman MCI; Mandal S
    BMJ Open Respir Res; 2023 Aug; 10(1):. PubMed ID: 37536948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern.
    McNamara RP; Maron JS; Boucau J; Roy V; Webb NE; Bertera HL; Barczak AK; Positives Study Staff T; Franko N; Logue JK; Kemp M; Li JZ; Zhou L; Hsieh CL; McLellan JS; Siedner MJ; Seaman MS; Lemieux JE; Chu HY; Alter G
    mBio; 2023 Aug; 14(4):e0090223. PubMed ID: 37535402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the COVID-19 Pandemic on Admission and Mortality Among Patients With Severe Emergency Diseases at Emergency Departments in Korea in 2020: Registry Data From the National Emergency Department Information System.
    Na SK; Kim JH; Lee WY; Oh MR
    J Korean Med Sci; 2023 Jul; 38(30):e243. PubMed ID: 37527913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with long COVID and mental health status among recovered COVID-19 patients in southern Thailand.
    Phu DH; Maneerattanasak S; Shohaimi S; Trang LTT; Nam TT; Kuning M; Like A; Torpor H; Suwanbamrung C
    PLoS One; 2023; 18(7):e0289382. PubMed ID: 37523396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection.
    Song J; Choi S; Jeong S; Chang JY; Park SJ; Oh YH; Kim JS; Cho Y; Byeon K; Choi JY; Lee S; Park SM
    Clin Res Cardiol; 2024 Feb; 113(2):235-245. PubMed ID: 37522901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omicron variant infection in inflammatory rheumatological conditions - outcomes from a COVID-19 naive population in Aotearoa New Zealand.
    Brooks J; Montgomery A; Dalbeth N; Sapsford M; Ngan Kee R; Cooper A; Quincey V; Bhana S; Gore-Massy M; Hausmann J; Liew J; Machado PM; Sufka P; Sirotich E; Robinson P; Wallace Z; Yazdany J; Grainger R
    Lancet Reg Health West Pac; 2023 Sep; 38():100843. PubMed ID: 37520279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable Efficacy of Lopinavir/Ritonavir and Remdesivir in Reducing Viral Load and Shedding Duration in Patients with COVID-19.
    Kim CM; Chung JK; Tamanna S; Bang MS; Tariq M; Lee YM; Seo JW; Kim DY; Yun NR; Seo J; Kim Y; Kim MJ; Kim DM; Cho NH
    Microorganisms; 2024 Aug; 12(8):. PubMed ID: 39203538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ways of the Virus: Interactions of Platelets and Red Blood Cells with SARS-CoV-2, and Their Potential Pathophysiological Significance in COVID-19.
    Panteleev MA; Sveshnikova AN; Shakhidzhanov SS; Zamaraev AV; Ataullakhanov FI; Rumyantsev AG
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    Kawasuji H; Morinaga Y; Tani H; Yoshida Y; Takegoshi Y; Kaneda M; Murai Y; Kimoto K; Ueno A; Miyajima Y; Fukui Y; Kimura M; Yamada H; Sakamaki I; Yamamoto Y
    J Med Virol; 2022 Jan; 94(1):147-153. PubMed ID: 34411312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.
    Tang K; Wu L; Luo Y; Gong B
    J Med Virol; 2021 May; 93(5):3165-3175. PubMed ID: 33590923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 antigenemia and RNAemia in association with disease severity in patients with COVID-19.
    Kim DM; Lawrence Panchali MJ; Kim CM; Lee DY; Seo JW; Kim DY; Yun NR
    Sci Rep; 2024 Jun; 14(1):14926. PubMed ID: 38942808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19.
    Bermejo-Martin JF; González-Rivera M; Almansa R; Micheloud D; Tedim AP; Domínguez-Gil M; Resino S; Martín-Fernández M; Ryan Murua P; Pérez-García F; Tamayo L; Lopez-Izquierdo R; Bustamante E; Aldecoa C; Gómez JM; Rico-Feijoo J; Orduña A; Méndez R; Fernández Natal I; Megías G; González-Estecha M; Carriedo D; Doncel C; Jorge N; Ortega A; de la Fuente A; Del Campo F; Fernández-Ratero JA; Trapiello W; González-Jiménez P; Ruiz G; Kelvin AA; Ostadgavahi AT; Oneizat R; Ruiz LM; Miguéns I; Gargallo E; Muñoz I; Pelegrin S; Martín S; García Olivares P; Cedeño JA; Ruiz Albi T; Puertas C; Berezo JÁ; Renedo G; Herrán R; Bustamante-Munguira J; Enríquez P; Cicuendez R; Blanco J; Abadia J; Gómez Barquero J; Mamolar N; Blanca-López N; Valdivia LJ; Fernández Caso B; Mantecón MÁ; Motos A; Fernandez-Barat L; Ferrer R; Barbé F; Torres A; Menéndez R; Eiros JM; Kelvin DJ
    Crit Care; 2020 Dec; 24(1):691. PubMed ID: 33317616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients.
    Lawrence Panchali MJ; Kim CM; Seo JW; Kim DY; Yun NR; Kim DM
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515246
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.